Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H(HK:1276)
HK$49.32-0.60 (-1.20%)
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H financials statements
HK$49.32
At close:-0.60 (-1.20%)
Want to see HK:1276 full AI Analyst Report?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Income Statement
9 Followers
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Income Statement
Last quarter (Q3 2026), Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's total revenue was HK$10.41B, an increase of 28.33% from the same quarter last year. In Q3, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's net income was HK$2.86B. See Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| HK$ 35.19B | HK$ 29.77B | HK$ 25.26B | HK$ 24.23B | HK$ 31.02B | |
| HK$ 30.33B | HK$ 25.68B | HK$ 21.36B | HK$ 20.26B | HK$ 26.20B | |
| HK$ 20.33B | HK$ 17.71B | HK$ 15.92B | HK$ 15.58B | HK$ 21.66B | |
| Depreciation and Amortization | HK$ 924.26M | HK$ 825.54M | HK$ 779.89M | HK$ 658.17M | HK$ 651.70M |
| HK$ 10.63B | HK$ 8.46B | HK$ 5.95B | HK$ 5.19B | HK$ 5.19B | |
| HK$ 10.00B | HK$ 7.97B | HK$ 5.43B | HK$ 4.68B | HK$ 4.54B | |
| HK$ -314.14M | HK$ -341.42M | HK$ -268.73M | HK$ -163.40M | HK$ 845.48M | |
| HK$ 9.69B | HK$ 7.63B | HK$ 5.17B | HK$ 4.52B | HK$ 5.38B | |
| HK$ 8.58B | HK$ 6.74B | HK$ 4.76B | HK$ 4.45B | HK$ 5.46B | |
| Per Share Metrics | |||||
| Basic EPS | HK$ 1.32 | HK$ 1.06 | HK$ 0.75 | HK$ 0.69 | HK$ 0.86 |
| Diluted EPS | HK$ 1.31 | HK$ 1.06 | HK$ 0.75 | HK$ 0.69 | HK$ 0.86 |
| Weighted Average Shares Outstanding | 6.48B | 6.34B | 6.33B | 6.40B | 6.38B |
| Weighted Average Shares Outstanding (Diluted) | 6.53B | 6.34B | 6.33B | 6.40B | 6.38B |
Currency in HKD

